Departments/Faculties
KNU School Of Medicine| Department | Division of Hemato-oncology |
|---|---|
| Introduction | The Division of Hemato-oncology is the first medical center in Korea established in the late 1950s primarily to treat blood-related malignant diseases. Thereafter, medical staff and researchers in the division have aimed at providing accurate diagnosis and the newest treatment for patients with malignant diseases. Through an elaborate clinical approach and remarkable academic achievements since 1958, when professor Ki-Seok Hwang established the hematology clinics and blood bank in the Kyungpook National University Hospital, they have been working at the cutting edge of modern medicine. At present in the hospital, sterile wards are perfectly running, and transplantation of bone marrow-derived hematopoietic stem cells or peripheral blood stem cells has been successfully carried out. In particular, in the early 1990s the division of hematology introduced the peripheral blood stem cell transplantation, which is presently acknowledged as a standard treatment for hematologic malignancy. Moreover, their studies on genetic polymorphism for hematologic malignancy including leukemia and lymphoma were published in the international peer-reviewed journals including Blood. Now they are actively involved in the studies of gene analysis for chronic myelogenous leukemia, new drug screening for bone marrow transplantation, and measurement of drug concentration of Gleevec used for the treatment of chronic myelogenous leukemia. Oncology section has also been recognized in the study fields of genetic polymorphism associated with the angiogenesis factor in colon and stomach cancer. Well-organized cooperative systems with the surgical teams in both research and clinical practice stimulate their activities significantly. Extensive basic and clinical research is now under way regarding discovery and functional study of colorectal cancer specific poly-miRTS. The main purpose of the research is to identify the novel biomarkers which could indicate the treatment efficacy of colon cancer. Recently several broadcast media introduced the Division of Hemato-oncology as a prestigious cancer center for the treatment and research in the country, indicating that the division has put enormous amount of efforts into the studies of malignant diseases. The division has played a leading role in this area by publishing more than fifty papers in international peer-reviewed journals.
|
| Professors | Chairman: Yee Soo Chae, MD, PhD Sang Kyun Sohn, MD, PhD
|